| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0028-3908(94)90074-4 |
| P698 | PubMed publication ID | 7984282 |
| P2093 | author name string | M A Geyer | |
| T A Sipes | |||
| P433 | issue | 3-4 | |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 441-448 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats | |
| P478 | volume | 33 |
| Q36834482 | 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats |
| Q36834486 | 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats |
| Q31870055 | 5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response |
| Q46084322 | 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice |
| Q46386540 | 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action |
| Q44407088 | 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment |
| Q30380379 | Abnormal neuronal activity in Tourette syndrome and its modulation using deep brain stimulation |
| Q46900363 | Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade |
| Q35105559 | Acute Psychological and Neurophysiological Effects of MDMA in Humans |
| Q46037792 | Aging effects on the startle response and startle plasticity in Fischer F344 rats. |
| Q50249534 | Animal Models of Hallucinations Observed Through the Modern Lens. |
| Q30395243 | Animal models of tic disorders: a translational perspective |
| Q33896472 | Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats |
| Q52192714 | Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. |
| Q46865467 | Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. |
| Q30358201 | Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. |
| Q36827431 | Challenge tests of monoaminergic systems: neurophysiological aspects |
| Q30482896 | Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice |
| Q41155219 | Cognitive effects of psychotomimetic drugs in rats discriminating number cues |
| Q43685844 | Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains |
| Q48650570 | Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition |
| Q48290612 | Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice |
| Q30501701 | Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats |
| Q46302008 | DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum |
| Q48481580 | Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats |
| Q46547612 | Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs |
| Q45279141 | Effect of Hallucinogens on Unconditioned Behavior |
| Q46881168 | Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. |
| Q50494942 | Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. |
| Q46976875 | Effects of experimental acute tryptophan depletion on acoustic startle response in females |
| Q41758224 | Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice |
| Q52202168 | Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. |
| Q41735609 | Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity |
| Q43774262 | Estrogen increases prepulse inhibition of acoustic startle in rats |
| Q52520208 | Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. |
| Q30477109 | Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. |
| Q46270285 | Functional behavioral homology between rat 5-HT1B and guinea pig 5-HT1D receptors in the modulation of prepulse inhibition of startle |
| Q30427588 | Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy |
| Q30497096 | Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats |
| Q30459497 | Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders |
| Q55613757 | Genetically Epilepsy-Prone Rats Display Anxiety-Like Behaviors and Neuropsychiatric Comorbidities of Epilepsy. |
| Q48108169 | Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats |
| Q30484494 | LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor |
| Q44405501 | Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice |
| Q90706103 | Maternal Overnutrition Induces Long-Term Cognitive Deficits across Several Generations |
| Q46961611 | Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. |
| Q24620764 | Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens |
| Q30435174 | Mutual independence of 5-HT(2) and α1 noradrenergic receptors in mediating deficits in sensorimotor gating |
| Q35597132 | Neuropharmacological profile of an atypical antipsychotic, NRA0562. |
| Q44859861 | Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist |
| Q42919813 | PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin |
| Q44727574 | Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users |
| Q35810066 | Pre-attentive processing and schizophrenia: animal studies |
| Q30359998 | Psychedelics |
| Q27027381 | Recent advances in the neuropsychopharmacology of serotonergic hallucinogens |
| Q44754229 | Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects |
| Q50857192 | Sensorimotor gating changes across the estrous cycle in female rats. |
| Q30467731 | Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha |
| Q30427074 | Serotonergic hallucinogens as translational models relevant to schizophrenia |
| Q47301476 | Serotonin Decreases the Gain of Visual Responses in Awake Macaque V1. |
| Q64218055 | Special issue on the psychopharmacology of prepulse inhibition: basic and clinical studies |
| Q43540875 | Structural and functional abnormalities of the hippocampal formation in rats with environmentally induced reductions in prepulse inhibition of acoustic startle |
| Q42633100 | The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats |
| Q41706989 | The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation |
| Q77297337 | The discovery of potent and selective dopamine D4 receptor antagonists |
| Q30489981 | The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats |
| Q30472666 | The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats |
| Q43842095 | The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval |
| Q33721045 | The neurobiology of startle |
| Q52525072 | The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition. |
Search more.